Michael is an expert on PDMP reporting as well as use of PDMP data in workflow. He has held positions with a major pharmacy chain, reporting to over 30 state PDMPs and with a major provider of PDMP data access. He has also been extensively involved with the development of PDMP reporting standards at both the National Council for Prescription Drug Plans (NCPDP) and the American Society for Automation in Pharmacy (ASAP). He is an advocate for judicious use of PDMP data to assist in assessing patient risk and is adamant that systematic analysis should initiate a conversation, not produce a clinical decision.